CNBC's Meg Tirrell reports Vertex's drug trials for cystic fibrosis were better than the Street expected.
Vertex is attempting to expand treatment options to about 40 percent of cystic fibrosis patients.
CNBC's Meg Tirrell reports that Vertex's cystic firbrosis drugs improve lung function and shares are popping after hours.
CNBC's Meg Tirrell reports on Vertex reporting results from its 3-drug cystic fibrosis combinations.
CNBC's Meg Tirrell reports on a jump in shares of Puma after the FDA approves a drug for breast cancer and the projected costs of the drug.
President Donald Trump has continually returned to two major themes when it comes to the pharmaceutical industry.
CNBC's Meg Tirrell report Johnson & Johnson kicks off health-care earnings with an EPS beat of $1.83 adj on revenues of $18.839 billion.
CNBC's Meg Tirrell reports on Puma moving higher after hours after the FDA approves their breast cancer drug.
CNBC's Meg Tirrell reports that Alexion Pharmaceuticals is being investigated by US Department of Health and Human Services Inspector General.
CNBC's Meg Tirrell reports on Martin Shkreli leaving the court house.